Taylor Chirisse, Fricker Ashwana D, Devi Lakshmi A, Gomes Ivone
Department of Pharmacology and Biological Chemistry, Mount Sinai School of Medicine, One Gustave L. Levy Place, New York, NY 10029, USA.
Cell Signal. 2005 May;17(5):549-57. doi: 10.1016/j.cellsig.2004.12.007.
Antidepressants are commonly used in the treatment of anxiety and depression, medical conditions that affect approximately 17-20% of the population. The clinical effects of antidepressants take several weeks to manifest, suggesting that these drugs induce adaptive changes in brain structures affected by anxiety and depression. In order to develop shorter-acting and more effective drugs for the treatment of anxiety and depression, it is important to understand how antidepressants bring about their beneficial effects. Recent reports suggest that antidepressants can induce neurogenesis in the adult brain, although the mechanisms involved are not clearly understood. In this review, we describe the different neurotransmitter systems that are affected by anxiety and depression and how they are modulated by antidepressant treatment with a focus on signaling molecules and pathways that are activated during neurotransmitter receptor induced neurogenesis.
抗抑郁药常用于治疗焦虑症和抑郁症,这些病症影响着约17%至20%的人口。抗抑郁药的临床效果需要数周时间才能显现,这表明这些药物会在受焦虑和抑郁影响的脑结构中引发适应性变化。为了开发作用时间更短、效果更显著的治疗焦虑症和抑郁症的药物,了解抗抑郁药如何产生有益效果至关重要。最近的报告表明,抗抑郁药可在成人大脑中诱导神经发生,尽管其中涉及的机制尚不清楚。在本综述中,我们描述了受焦虑和抑郁影响的不同神经递质系统,以及抗抑郁治疗如何对其进行调节,重点关注神经递质受体诱导神经发生过程中被激活的信号分子和信号通路。